In non-small cell lung cancer (NSCLC), JMJD8 enhances the proliferation and invasion of cancer cells by stabilizing the epidermal growth factor receptor (EGFR), thereby inhibiting the degradation of the overexpressed EGFR (7). This evidence concerns the gene EGFR and non-small cell lung carcinoma.